MCL coexpression mm9:2343: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0000007!4.07e-11!8;UBERON:0003296!4.07e-11!8;UBERON:0010133!4.07e-11!8;UBERON:0000970!3.77e-10!9;UBERON:0000019!3.77e-10!9;UBERON:0000047!3.77e-10!9;UBERON:0010312!3.77e-10!9;UBERON:0004088!3.77e-10!9;UBERON:0002104!3.77e-10!9;UBERON:0001456!3.77e-10!9;UBERON:0003072!3.77e-10!9;UBERON:0004128!3.77e-10!9;UBERON:0003071!3.77e-10!9;UBERON:0001894!7.29e-10!10;UBERON:0006222!7.29e-10!10;UBERON:0001444!7.79e-08!11;UBERON:0000020!5.64e-07!12;UBERON:0001032!5.64e-07!12;UBERON:0004456!5.64e-07!12 | |ontology_enrichment_uberon=UBERON:0000007!4.07e-11!8;UBERON:0003296!4.07e-11!8;UBERON:0010133!4.07e-11!8;UBERON:0000970!3.77e-10!9;UBERON:0000019!3.77e-10!9;UBERON:0000047!3.77e-10!9;UBERON:0010312!3.77e-10!9;UBERON:0004088!3.77e-10!9;UBERON:0002104!3.77e-10!9;UBERON:0001456!3.77e-10!9;UBERON:0003072!3.77e-10!9;UBERON:0004128!3.77e-10!9;UBERON:0003071!3.77e-10!9;UBERON:0001894!7.29e-10!10;UBERON:0006222!7.29e-10!10;UBERON:0001444!7.79e-08!11;UBERON:0000020!5.64e-07!12;UBERON:0001032!5.64e-07!12;UBERON:0004456!5.64e-07!12 | ||
|tfbs_overrepresentation_for_novel_motifs=1.54788,1.30284,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.489964,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,1.2676,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.906602,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.854272,1.2563,0.089443,1.16474,0.786577,1.10929,0.40068,0.478558,0.717547,0.185353,0.504971,0.325217,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,0.37865,1.04072,0.884013,0.362446,1.20828,0.11855,0.40635,0.791209,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,1.16494,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,1.4032,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.442329,0.692434,1.02384,1.15537,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.195549,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.79777,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,1.16191,0.788782,0.0824127 | |||
}} | }} |
Revision as of 21:16, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr2:26062055..26062100,- | p1@Lhx3 |
Mm9::chr3:128917187..128917223,+ | p2@Pitx2 |
Mm9::chr4:114353374..114353387,+ | p1@ENSMUST00000146346 |
Mm9::chr4:132212598..132212620,+ | p2@Eya3 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0002074 | extraocular skeletal muscle development | 0.0106829726957006 |
GO:0021526 | medial motor column neuron differentiation | 0.0106829726957006 |
GO:0021523 | somatic motor neuron differentiation | 0.0106829726957006 |
GO:0016477 | cell migration | 0.0106829726957006 |
GO:0006928 | cell motility | 0.0106829726957006 |
GO:0051674 | localization of cell | 0.0106829726957006 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.0106829726957006 |
GO:0021517 | ventral spinal cord development | 0.0106829726957006 |
GO:0021522 | spinal cord motor neuron differentiation | 0.0106829726957006 |
GO:0006351 | transcription, DNA-dependent | 0.0106829726957006 |
GO:0032774 | RNA biosynthetic process | 0.0106829726957006 |
GO:0045449 | regulation of transcription | 0.0106829726957006 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0106829726957006 |
GO:0021515 | cell differentiation in spinal cord | 0.0106829726957006 |
GO:0006350 | transcription | 0.0106829726957006 |
GO:0010468 | regulation of gene expression | 0.0106829726957006 |
GO:0008045 | motor axon guidance | 0.0106829726957006 |
GO:0031323 | regulation of cellular metabolic process | 0.0106829726957006 |
GO:0005667 | transcription factor complex | 0.0106829726957006 |
GO:0007275 | multicellular organismal development | 0.0106829726957006 |
GO:0043565 | sequence-specific DNA binding | 0.0106829726957006 |
GO:0019222 | regulation of metabolic process | 0.0106829726957006 |
GO:0016070 | RNA metabolic process | 0.0110493901619487 |
GO:0021510 | spinal cord development | 0.0126334477114474 |
GO:0044451 | nucleoplasm part | 0.0135941983933731 |
GO:0005654 | nucleoplasm | 0.014343789265851 |
GO:0010467 | gene expression | 0.0161329466883877 |
GO:0001569 | patterning of blood vessels | 0.0175015391550872 |
GO:0032502 | developmental process | 0.0175015391550872 |
GO:0031981 | nuclear lumen | 0.0175015391550872 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.018891367133842 |
GO:0031974 | membrane-enclosed lumen | 0.0201809521190785 |
GO:0043233 | organelle lumen | 0.0201809521190785 |
GO:0050794 | regulation of cellular process | 0.0209059308120826 |
GO:0007368 | determination of left/right symmetry | 0.0209059308120826 |
GO:0003700 | transcription factor activity | 0.0209059308120826 |
GO:0009799 | determination of symmetry | 0.0209059308120826 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 0.0209059308120826 |
GO:0009855 | determination of bilateral symmetry | 0.0209059308120826 |
GO:0009880 | embryonic pattern specification | 0.0232887950107526 |
GO:0050789 | regulation of biological process | 0.0243381377615282 |
GO:0044428 | nuclear part | 0.0277722567323495 |
GO:0030334 | regulation of cell migration | 0.0281446682715988 |
GO:0065007 | biological regulation | 0.0293068929892983 |
GO:0048754 | branching morphogenesis of a tube | 0.0293068929892983 |
GO:0051270 | regulation of cell motility | 0.0293068929892983 |
GO:0005634 | nucleus | 0.0293068929892983 |
GO:0032501 | multicellular organismal process | 0.0293068929892983 |
GO:0001763 | morphogenesis of a branching structure | 0.0293068929892983 |
GO:0040012 | regulation of locomotion | 0.0293068929892983 |
GO:0009653 | anatomical structure morphogenesis | 0.0295624142412393 |
GO:0043283 | biopolymer metabolic process | 0.0299229790417025 |
GO:0043010 | camera-type eye development | 0.0328926402552631 |
GO:0007411 | axon guidance | 0.0339978428144898 |
GO:0004725 | protein tyrosine phosphatase activity | 0.0363234407530172 |
GO:0007519 | skeletal muscle development | 0.0393887586386873 |
GO:0001654 | eye development | 0.0423429060598864 |
GO:0006470 | protein amino acid dephosphorylation | 0.0424084470269759 |
GO:0016311 | dephosphorylation | 0.0463684940195847 |
GO:0016055 | Wnt receptor signaling pathway | 0.0463684940195847 |
GO:0014706 | striated muscle development | 0.0463684940195847 |
GO:0043234 | protein complex | 0.0471863066083069 |
GO:0001525 | angiogenesis | 0.0496450739327506 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
pituitary gland | 4.07e-11 | 8 |
gland of diencephalon | 4.07e-11 | 8 |
neuroendocrine gland | 4.07e-11 | 8 |
eye | 3.77e-10 | 9 |
camera-type eye | 3.77e-10 | 9 |
simple eye | 3.77e-10 | 9 |
immature eye | 3.77e-10 | 9 |
ocular region | 3.77e-10 | 9 |
visual system | 3.77e-10 | 9 |
face | 3.77e-10 | 9 |
optic cup | 3.77e-10 | 9 |
optic vesicle | 3.77e-10 | 9 |
eye primordium | 3.77e-10 | 9 |
diencephalon | 7.29e-10 | 10 |
future diencephalon | 7.29e-10 | 10 |
subdivision of head | 7.79e-08 | 11 |
sense organ | 5.64e-07 | 12 |
sensory system | 5.64e-07 | 12 |
entire sense organ system | 5.64e-07 | 12 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |